187 related articles for article (PubMed ID: 31256701)
1. Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the
Wang F; Chen Y; Jiang N; Gong S; Cao T; Yuan J; Liu J; Xie L; Wu Y; Jia Y
Leuk Lymphoma; 2019 Dec; 60(13):3304-3307. PubMed ID: 31256701
[No Abstract] [Full Text] [Related]
2. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
[No Abstract] [Full Text] [Related]
3. MLL-SEPT5 Fusion Transcript in Two de novo Acute Myeloid Leukemia Patients With t(11;22)(q23;q11).
Wang N; Wu X; Sheng G; Ma L; Wen L; Yao H; Chen S
Ann Lab Med; 2016 Sep; 36(5):501-3. PubMed ID: 27374720
[No Abstract] [Full Text] [Related]
4. Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25).
Santos J; Cerveira N; Correia C; Lisboa S; Pinheiro M; Torres L; Bizarro S; Vieira J; Viterbo L; Mariz JM; Teixeira MR
Cancer Genet Cytogenet; 2010 Feb; 197(1):60-4. PubMed ID: 20113838
[TBL] [Abstract][Full Text] [Related]
5. Emergence of two unrelated clones in acute myeloid leukemia with MLL-SEPT9 fusion transcript.
Saito H; Otsubo K; Kakimoto A; Komatsu N; Ohsaka A
Cancer Genet Cytogenet; 2010 Sep; 201(2):111-5. PubMed ID: 20682395
[TBL] [Abstract][Full Text] [Related]
6. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.
Lee SG; Park TS; Oh SH; Park JC; Yang YJ; Marschalek R; Meyer C; Cho EH; Shin SY
Acta Haematol; 2011; 126(4):195-8. PubMed ID: 21846973
[No Abstract] [Full Text] [Related]
7. TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia.
Herbaux C; Poulain S; Meyer C; Marschalek R; Renneville A; Fernandes J; Theisen O; Tricot S; Simon M; Duthilleul P; Daudignon A
Br J Haematol; 2012 Apr; 157(1):128-31. PubMed ID: 22050635
[No Abstract] [Full Text] [Related]
8. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
[TBL] [Abstract][Full Text] [Related]
9. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
Duhoux FP; De Wilde S; Ameye G; Bahloula K; Medves S; Légé G; Libouton JM; Demoulin JB; A Poirel H
Leuk Res; 2011 Mar; 35(3):e18-20. PubMed ID: 20980053
[No Abstract] [Full Text] [Related]
10. Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis.
Ma YY; Zhao M; Liu Y; Zhao DF; Wang LX; Chen XP; Li L
Hematology; 2019 Dec; 24(1):507-515. PubMed ID: 31242832
[No Abstract] [Full Text] [Related]
11. Refractory pediatric acute myeloid leukemia expressing NUP98-NSD1 fusion gene responsive to chemotherapy combined with venetoclax and decitabine.
Xu H; Yu H; Xu J; Zhou F; Tang S; Feng X; Luo Q; Zhang B; Wu X; Jin R; Chen H
Pediatr Blood Cancer; 2023 Mar; 70(3):e30021. PubMed ID: 36184746
[No Abstract] [Full Text] [Related]
12. A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene.
Zerkalenkova E; Lebedeva S; Kazakova A; Baryshev P; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
Genes Chromosomes Cancer; 2018 Oct; 57(10):522-524. PubMed ID: 30107050
[TBL] [Abstract][Full Text] [Related]
13. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).
Launay E; Henry C; Meyer C; Chappé C; Taque S; Boulland ML; Ben Abdelali R; Dugay F; Marschalek R; Bastard C; Fest T; Gandemer V; Belaud-Rotureau MA
Leuk Lymphoma; 2014 Mar; 55(3):662-7. PubMed ID: 23725386
[TBL] [Abstract][Full Text] [Related]
14. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25).
Kurosu T; Tsuji K; Ohki M; Miki T; Yamamoto M; Kakihana K; Koyama T; Taniguchi S; Miura O
Int J Hematol; 2008 Sep; 88(2):192-196. PubMed ID: 18642054
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.
Gardner R; Wu D; Cherian S; Fang M; Hanafi LA; Finney O; Smithers H; Jensen MC; Riddell SR; Maloney DG; Turtle CJ
Blood; 2016 May; 127(20):2406-10. PubMed ID: 26907630
[TBL] [Abstract][Full Text] [Related]
16. The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias.
Duhoux FP; Ameye G; Libouton JM; Bahloula K; Iossifidis S; Chantrain CF; Demoulin JB; Poirel HA
Leuk Res; 2011 Sep; 35(9):e171-2. PubMed ID: 21620472
[No Abstract] [Full Text] [Related]
17. A complex t(1;22;11)(q44;q13;q23) translocation causing MLL-p300 fusion gene in therapy-related acute myeloid leukemia.
Ohnishi H; Taki T; Yoshino H; Takita J; Ida K; Ishii M; Nishida K; Hayashi Y; Taniwaki M; Bessho F; Watanabe T
Eur J Haematol; 2008 Dec; 81(6):475-80. PubMed ID: 18778367
[TBL] [Abstract][Full Text] [Related]
18.
Britten O; Ragusa D; Tosi S; Kamel YM
Cells; 2019 Oct; 8(11):. PubMed ID: 31671855
[TBL] [Abstract][Full Text] [Related]
19. Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axis.
Cao Y; Liu Y; Shang L; Wei W; Shen Y; Gu Q; Xie X; Dong W; Lin Y; Yue Y; Wang F; Gu W
Biomed Pharmacother; 2020 May; 125():109878. PubMed ID: 32006898
[TBL] [Abstract][Full Text] [Related]
20. 11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
Chin LK; Cheah CY; Michael PM; MacKinnon RN; Campbell LJ
Leuk Lymphoma; 2012 Oct; 53(10):2066-8. PubMed ID: 22335556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
